Clinical Study | Open Access
Michele Maruccia, Maria G. Onesti, Valentina Sorvillo, Antonio Albano, Luca A. Dessy, Bruno Carlesimo, Mauro Tarallo, Marco Marcasciano, Giuseppe Giudice, Emanuele Cigna, Diego Ribuffo, "An Alternative Treatment Strategy for Complicated Chronic Wounds: Negative Pressure Therapy over Mesh Skin Graft", BioMed Research International, vol. 2017, Article ID 8395219, 7 pages, 2017. https://doi.org/10.1155/2017/8395219
An Alternative Treatment Strategy for Complicated Chronic Wounds: Negative Pressure Therapy over Mesh Skin Graft
Extensive skin defect represents a real problem and major challenge in plastic and reconstructive surgery. On one hand, skin grafts offer a practical method to deal with skin defects despite their unsuitability for several complicated wounds. On the other hand, negative pressure wound therapy (NPWT), applied before skin grafting, promotes granulation tissue growth. The aim of the study is to evaluate the improvement in wound healing given by the merger of these two different approaches. We treated 23 patients for large wounds of multiple factors. Of these, 15 were treated with the application of V.A.C.® Therapy (KCI Medical S.r.l., Milan, Italy), in combination with skin grafts after a prior unsuccessful treatment of 4 weeks with mesh skin grafts and dressings. Another 8 were treated with only mesh skin graft. Pain reduction and wound area reduction were found statistically significant (, ). Infection was resolved in almost all patients. According to our study, the use of the negative pressure wound therapy over mesh skin grafts is significantly effective especially in wounds resistant to conventional therapies, thereby improving the rate of skin graft take.
Chronic wounds, which typically result from medical conditions, nutritional deficiencies, infections, and metabolic disorders, involve intensive and time-consuming treatments . Extensive skin defect is a great challenge and a major problem in plastic and reconstructive surgery. The use of skin grafts, whether split thickness or full thickness, has offered a reasonable method to address this problem. However the sole use of skin autologous grafts in complicated wounds might be not entirely satisfactory .
Negative pressure wound therapy (NPWT) is a therapeutic technique, which facilitates the healing of acute and chronic wounds . NPWT, which deters the accumulation of fluid at wound sites through continuous drainage, makes daily dressing changes unnecessary, improves regional blood flow, and reduces bacterial proliferation, thus reducing the chances of infection . NPWT can be successfully used before skin grafting, promoting granulation tissue growth with a 54% increase in growth rate and improving the survival rate of free skin graft [2–6].
The aim of the study is to evaluate the improvement in wound healing given by the merger of these two different approaches. Thereby the study underlines the crucial role of NPWT applied not only before but also on top of skin grafts. Our clinical study compares application of V.A.C. Therapy (KCI Medical S.r.l, Milan, Italy) in combination with skin grafts to repair acute and chronic wounds with the treatment of the same wounds covered only by a conventional skin graft.
2. Material/Patients and Methods
The study took place from January 2014 to June 2015 in the Department of Plastic and Reconstructive Surgery of “Sapienza” University of Rome.
A group of 23 patients were treated for large wounds of multiple factors. Of these 15 were treated with the application of V.A.C. Therapy (KCI Medical S.r.l, Milan, Italy), in combination with skin grafts after a prior unsuccessful treatment of 4 weeks with mesh skin grafts and dressing. Another 8 were treated with the only mesh skin graft. Inclusion criteria were wound area > 70 cm2. Exclusion criteria were patients with diabetes mellitus, patients treated with corticosteroids, and uncollaborative patients. Treatment was carried out on all by the same team.
A prospective-comparative study between mesh skin graft (SG) and mesh skin graft plus NPWT (SG+) was carried out evaluating several objective and subjective data before and after treatments on the same patient. The data collected before the first and the second treatment were disease duration, presence of pain, and wound characteristics such as size, exudation, and pain. In addition, a bacterial culture and sensitivity were performed for all the patients at the beginning of the treatment; after two weeks of SG; after 4 weeks; at the end of the first phase; and after two weeks of SG+. Before surgery, photos were made for every candidate.
All patients underwent the same surgical protocol: in the first period, a mesh skin graft was placed and treated in traditional way (wet gauze application and compression). Whenever mesh skin grafts failed (4 weeks after surgery) the innovative surgical protocol was applied: wound disinfection with chlorine-based disinfectant and povidone-iodine, washing with saline solution, and application of mesh skin grafts. In addition NPWT was placed over the wet gauze for compression and immobilization. NPWT was set at −75 mmHg of aspiration. After five days the dressing was changed for a first evaluation of engraftment. NPWT was in place until grafts were engrafted and no more exudation was present (Figures 1–5(b)).
After 4 weeks of treatment (either SG and SG+) results were evaluated taking into account wound area (assessed as an ellipsoid) , status of the grafts, cultural examination, and pain relief. In order to describe subjective pain sensation, visual analogic scale (VAS) was submitted to the patients at the start of the treatment and on a weekly basis during the 2-month study period. A range from 1 (no pain) to 10 (maximum pain level) was considered. Wound margins were evaluated for necrosis, dermatitis, or, on the contrary, full integrity; periwound skin was evaluated for erythema, edema, and full integrity. Pain relief and area reduction were compared and analyzed using Student’s t-test in two groups.
Of the 23 patients treated in this study, 14 were males and 9 were females. Epidemiological data showed an average of 52 years (between 19 and 87 years). Etiologies were manifold: 15 had chronic vascular wound and 8 posttraumatic ulcers. In the first 4 weeks of treatment, complete healing occurred in 8 patients.
Complete healing occurred in 14 patients over a period of 10 weeks (6 of SG+). Complete initial engraftment occurred in 12 patients over a period of 8 weeks (4 of SG+). Only 1 patient was partially responsive to both treatments. In any case a remarkable reduction in wound exudation, edema, and perilesional margins was registered. Pain reduction was significant during the first period in 8 patients (average reduction of 1 point in the first week and 2.3 points at the end of the fourth week), the same ones whose wounds healed at the end of the fourth week. Pain reduction was significant in the second period in all patients not healed (15), with an average reduction of 2.1 points in the first week and 4 after 6 weeks.
An interesting trend was highlighted in the 15 patients entered in the second stage of therapy. In fact in the first 4 weeks of treatment only an average pain reduction of 1.04 points was reported, quite insignificant in comparison with the 2.13-point reduction after the first week of SG+ treatment (). Another interesting piece of data was the comparison between pain relief after the first phase (mean = 3.39) and the second phase (mean = 6.13) with a (Tables 1 and 2).
|(a) Comparison of pain relief in week 1 and week 5|
|(b) Comparison of pain relief in week 4 and week 10|
|(c) Comparison of pain relief in first treatment (SG) and second treatment (SG+)|
Taking into account the second analyzed parameter, wound area reduction, significant results were found (, ); a mean reduction of 40.5% was found in the first period in comparison with 96.3% in the second period (Tables 3 and 4).
| = number of patients, M = mean, = value, 95% ci = 95% confidence interval, df = degree of freedom, sed = standard error of difference, and = value.|
Cultural examinations of wound exudates at time 0 showed 8 patients positive for Staphylococcus aureus, 2 for Pseudomonas aeruginosa, and 1 for Enterococcus faecalis. After two weeks of SG, 7 patients were positive for Staphylococcus aureus, 2 for Pseudomonas aeruginosa, and 1 for Enterococcus faecalis. After 4 weeks Staphylococcus aureus was present in 5 patients, Pseudomonas aeruginosa in 2 patients, and Enterococcus faecalis in 1 patient. Cultural examinations were repeated after 2 weeks of SG+ and shown the presence of Staphylococcus aureus in 2 patients and Pseudomonas aeruginosa in 1 patient (Table 5).
|SA = Staphylococcus aureus; PA = Pseudomonas aeruginosa; EF = Enterococcus faecalis.|
Chronic ulcer usually means an injury neither spontaneously evolving towards healing nor progressing through normal stages of healing such as inflammation, proliferation, and remodeling. This condition represents a serious physical and psychological limit to the patient as well as being a burden for the health system .
Treatments in patients with chronic wounds usually consist in debridement and skin grafts. An important innovation in chronic wounds management is the use of NPWT over the skin graft. Our advice would be a trick we developed: use 75 mmHg negative pressure on the skin graft instead of 125 mmHg. In our experience this is very important in order to allow good adhesion of the skin graft to the wound bed during initial engraftment. We evaluated the data reported and highlighted a marked and statistically significant improvement in the treatment of large loss of substance through mesh skin grafts dressed with V.A.C. Therapy system (). In fact, taking into account the 23 patients enrolled in the study, it was pointed out that only 8 of them healed through traditional treatment, while the remaining 14 out of 15 healed with the modified treatment in 6 weeks. These data provide us with various interpretations: the 15 patients who remained in the study were those who had a wound whose healing was trickier. It is also interesting to evaluate how the data “pain relief” strongly and quickly improved (in a statistically significant way) already after the first week of SG+ treatment in the group of patients who had reported only a marginal improvement in the first phase of the study.
Another important fact to consider is the presence of infection in the examination cultures after 4 weeks (end of the first phase of treatment) in comparison with the examination carried out after 6 weeks. In fact after 4 weeks 5 people reported positive culture examination for S. aureus infection, 2 P. aeruginosa, and 1 E. faecalis; after only 2 weeks of treatment with SG+NPWT only 2 people still had positive wound swab for S. aureus and 1 P. aeruginosa. We observed also an improvement of the other signs and symptoms of infection as purulent discharge from the wound, pain, swelling, and redness. With the data available we can say that the use of NPWT above mesh skin grafts is significantly better than the mesh skin grafts alone. In addition it showed a faster recovery and a better dressing management and a reduced number of dressing changes. Numerous studies have been carried out on the combined use of NPWT over dermal substitutes also to cover large and deep wounds (including bone and tendon exposure) [7–13]. Every study assessed that, thanks to the integrated use of these techniques, the preparation of the wound bed was quicker in order to obtain a better graft take . In fact NPWT used over the dermal template delivered a faster maturation (approximately 1-2 weeks) and a higher integration quality [15, 16]. This integrated technique keeps the matrix immobilized, leaves the wound bed moist and free of debris, prevents the accumulation of fluid collections, and reduces bacterial colonization of the wound . Likewise biological semipermeable membranes, connected through drainage tubes to vacuum source, create a fully closed negative pressure drainage condition promoting the expulsion of effusion and liquefied necrotic tissue in the cavities . This kind of dressing results in a better immobilization of the graft, thereby limiting shear forces, eliminating fluid collections, bridging of the graft, and decreasing bacterial contamination.
According to our study the use of the negative pressure wound therapy over mesh skin grafts is dramatically effective especially in wounds resistant to conventional therapies. Although there are no current studies on the two techniques combined, our data are comparable to those on the integration of dermal substitutes and NPWT.
None of the authors has any conflict of interests or financial interests in any of the products, devices, or drugs mentioned in this manuscript. None of the authors has any financial or personal relationships with other people or organizations that could inappropriately influence their work.
- C. A. Arias and B. E. Murray, “Antibiotic-resistant bugs in the 21st century—a clinical super-challenge,” New England Journal of Medicine, vol. 360, no. 5, pp. 439–443, 2009.
- J. Chen, Z.-J. Tang, Z.-F. Xia, X.-D. Zheng, and L.-C. Zhang, “Influence of polyester gauze on evaporation capacity and healing of the surface of microskin graft wound after escharectomy,” Zhonghua Yi Xue Za Zhi, vol. 89, no. 2, pp. 105–108, 2009 (Chinese).
- E. H. E. W. De Laat, M. H. W. A. Van Den Boogaard, P. H. M. Spauwen, D. H. J. M. Van Kuppevelt, H. Van Goor, and L. Schoonhoven, “Faster wound healing with topical negative pressure therapy in difficult-to-heal wounds: a prospective randomized controlled trial,” Annals of Plastic Surgery, vol. 67, no. 6, pp. 626–631, 2011.
- M. Kaplan, D. Daly, and S. Stemkowski, “Early intervention of negative pressure wound therapy using Vacuum-Assisted Closure in trauma patients: impact on hospital length of stay and cost,” Advances in Skin & Wound Care, vol. 22, no. 3, pp. 128–132, 2009.
- E. Krug, L. Berg, C. Lee et al., “International Expert Panel on Negative Pressure Wound Therapy [NPWT-EP]. Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus,” Injury, vol. 42, supplement 1, pp. S1–S12, 2011.
- D. A. Milcheski, A. A. Chang, R. C. Lobato, H. A. Nakamoto, P. Tuma Jr., and M. C. Ferreira, “Coverage of deep cutaneous wounds using dermal template in combination with negative-pressure therapy and subsequent skin graft,” Plastic and Reconstructive Surgery—Global Open, vol. 2, no. 6, p. e170, 2014.
- M. G. Onesti, P. Fioramonti, S. Carella, and M. Maruccia, “The importance of periwound skin in the treatment of ‘difficult wound’,” Il Giornale di Chirurgia, vol. 32, no. 1-2, pp. 83–88, 2011.
- M. D. Helgeson, B. K. Potter, K. N. Evans, and S. B. Shawen, “Bioartificial dermal substitute: a preliminary report on its use for the management of complex combat-related soft tissue wounds,” Journal of Orthopaedic Trauma, vol. 21, no. 6, pp. 394–399, 2007.
- M. L. Iorio, J. Shuck, and C. E. Attinger, “Wound healing in the upper and lower extremities: a systematic review on the use of acellular dermal matrices,” Plastic and reconstructive surgery, vol. 130, no. 5, S2, pp. 232S–241S, 2012.
- E. Cigna, M. Maruccia, V. Sorvillo, P. Parisi, F. Palumbo, and M. G. Onesti, “The use of negative pressure therapy and hyaluronic acid for the management of post-traumatic lower limb injury,” International Wound Journal, vol. 10, no. 5, pp. 534–538, 2013.
- P. Violas, A. Abid, P. Darodes, P. Galinier, J. S. De Gauzy, and J.-P. Cahuzac, “Integra artificial skin in the management of severe tissue defects, including bone exposure, in injured children,” Journal of Pediatric Orthopaedics Part B, vol. 14, no. 5, pp. 381–384, 2005.
- N. S. Moiemen, J. Yarrow, D. Kamel, D. Kearns, and D. Mendonca, “Topical negative pressure therapy: does it accelerate neovascularisation within the dermal regeneration template, Integra? A prospective histological in vivo study,” Burns, vol. 36, no. 6, pp. 764–768, 2010.
- P. Fioramonti, P. Fino, P. Parisi, N. Scuderi, and M. G. Onesti, “A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase,” In Vivo, vol. 26, no. 6, pp. 1053–1056, 2012.
- M. G. Onesti, P. Fioramonti, P. Fino, V. Sorvillo, S. Carella, and N. Scuderi, “Effect of enzymatic debridement with two different collagenases versus mechanical debridement on chronic hard-to-heal wounds,” International Wound Journal, vol. 13, no. 6, pp. 1111–1115, 2016.
- M. Fraccalvieri, G. Pristerà, E. Zingarelli, E. Ruka, and S. Bruschi, “Treatment of chronic heel osteomyelitis in vasculopathic patients. Can the combined use of Integra®, skin graft and negative pressure wound therapy be considered a valid therapeutic approach after partial tangential calcanectomy?” International Wound Journal, vol. 9, no. 2, pp. 214–220, 2012.
- M. G. Jeschke, C. Rose, P. Angele, B. Füchtmeier, M. N. Nerlich, and U. Bolder, “Development of new reconstructive techniques: use of integra in combination with fibrin glue and negative-pressure therapy for reconstruction of acute and chronic wounds,” Plastic and Reconstructive Surgery, vol. 113, no. 2, pp. 525–530, 2004.
- C. M. Mouës, G. J. C. M. van den Bemd, F. Heule, and S. E. R. Hovius, “Comparing conventional gauze therapy to vacuum-assisted closure wound therapy: a prospective randomised trial,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 60, no. 6, pp. 672–681, 2007.
Copyright © 2017 Michele Maruccia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.